Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 33

Results: 15

Thyroid hormone suppresses cell proliferation through endoglin-mediated promotion of p21 stability.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3904, doi. 10.1038/onc.2013.5

By:

Lin, Y-H;
Huang, Y-H;
Wu, M-H;
Wu, S-M;
Chi, H-C;
Liao, C-J;
Chen, C-Y;
Tseng, Y-H;
Tsai, C-Y;
Tsai, M-M;
Lin, K-H

Publication type:

Article

The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3840, doi. 10.1038/onc.2012.399

By:

Koyama-Nasu, R;
Nasu-Nishimura, Y;
Todo, T;
Ino, Y;
Saito, N;
Aburatani, H;
Funato, K;
Echizen, K;
Sugano, H;
Haruta, R;
Matsui, M;
Takahashi, R;
Manabe, E;
Oda, T;
Akiyama, T

Publication type:

Article

Gene signature critical to cancer phenotype as a paradigm for anticancer drug discovery.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3809, doi. 10.1038/onc.2012.389

By:

Sampson, E R;
McMurray, H R;
Hassane, D C;
Newman, L;
Salzman, P;
Jordan, C T;
Land, H

Publication type:

Article

The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3819, doi. 10.1038/onc.2012.406

By:

Guan, D;
Factor, D;
Liu, Yu;
Wang, Z;
Kao, H-Y

Publication type:

Article

YAP1 oncogene and its eight isoforms.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3922, doi. 10.1038/onc.2012.520

By:

Sudol, M

Publication type:

Article

EZH2 promotes a bi-lineage identity in basal-like breast cancer cells.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3886, doi. 10.1038/onc.2012.390

By:

Granit, R Z;
Gabai, Y;
Hadar, T;
Karamansha, Y;
Liberman, L;
Waldhorn, I;
Gat-Viks, I;
Regev, A;
Maly, B;
Darash-Yahana, M;
Peretz, T;
Ben-Porath, I

Publication type:

Article

C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3896, doi. 10.1038/onc.2012.380

By:

Barroilhet, L;
Yang, J;
Hasselblatt, K;
Paranal, R M;
Ng, S-K;
Rauh-Hain, J A;
Welch, W R;
Bradner, J E;
Berkowitz, R S;
Ng, S-W

Publication type:

Article

BMP-specific SMADs function as novel repressors of PDGFA and modulate its expression in ovarian granulosa cells and tumors.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3877, doi. 10.1038/onc.2012.392

By:

Tripurani, S K;
Cook, R W;
Eldin, K W;
Pangas, S A

Publication type:

Article

The tumor suppressor Caliban regulates DNA damage-induced apoptosis through p53-dependent and -independent activity.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3857, doi. 10.1038/onc.2012.395

By:

Wang, Y;
Wang, Z;
Joshi, B H;
Puri, R K;
Stultz, B;
Yuan, Q;
Bai, Y;
Zhou, P;
Yuan, Z;
Hursh, D A;
Bi, X

Publication type:

Article

Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3829, doi. 10.1038/onc.2012.405

By:

Ketchart, W;
Smith, K M;
Krupka, T;
Wittmann, B M;
Hu, Y;
Rayman, P A;
Doughman, Y Q;
Albert, J M;
Bai, X;
Finke, J H;
Xu, Y;
Exner, A A;
Montano, M M

Publication type:

Article

AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3867, doi. 10.1038/onc.2012.394

By:

Norris, A M;
Gore, A;
Balboni, A;
Young, A;
Longnecker, D S;
Korc, M

Publication type:

Article

Various modes of cell death induced by DNA damage.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3789, doi. 10.1038/onc.2012.556

By:

Surova, O;
Zhivotovsky, B

Publication type:

Article

MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3915, doi. 10.1038/onc.2012.403

By:

Franzetti, G-A;
Laud-Duval, K;
Bellanger, D;
Stern, M-H;
Sastre-Garau, X;
Delattre, O

Publication type:

Article

FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3798, doi. 10.1038/onc.2012.393

By:

Dikshit, B;
Irshad, K;
Madan, E;
Aggarwal, N;
Sarkar, C;
Chandra, P S;
Gupta, D K;
Chattopadhyay, P;
Sinha, S;
Chosdol, K

Publication type:

Article

HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors.

Published in:

Oncogene, 2013, v. 32, n. 33, p. 3846, doi. 10.1038/onc.2012.396

By:

Gusenbauer, S;
Vlaicu, P;
Ullrich, A

Publication type:

Article